期刊文献+

来氟米特治疗类风湿关节炎的疗效

The effect of leflunomide in the treatment of rheumatoid arthritis
下载PDF
导出
摘要 目的:探讨来氟米特治疗类风湿关节炎的疗效。方法:2016年1月-2019年5月收治类风湿关节炎患者40例,随机分为两组,各20例。对照组使用甲氨蝶呤治疗;观察组使用甲氨蝶呤加来氟米特治疗。比较两组治疗效果。结果:观察组治疗总有效率明显高于对照组,观察组治疗后CRP及ESR水平明显低于对照组,观察组治疗后关节肿胀个数、关节压痛个数、关节功能评级、晨僵时间均优于对照组,差异均有统计学意义(P<0.05);结论:来氟米特治疗类风湿关节炎效果显著,能有效改善关节症状,降低CRP及ESR水平。 Objective:To study the efficacy of leflunomide in the treatment of rheumatoid arthritis.Methods:From January 2016 to May 2019,40 patients with rheumatoid arthritis were treated.They were randomly divided into the two groups with 20 cases in each group.The control group was treated with methotrexate.The observation group was treated with methotrexate combined with leflunomide.We compared the treatment effects between groups.Results:The total effective rate of the observation group was significantly higher than the control group;the level of CRP and ESR after treatment in the observation group was significantly lower than the control group;the number of joint swelling,the number of joint tenderness,the rating of joint function and the time of morning stiffness in the observation group were better than the control group after treatment;the differences were statistically significant(P<0.05).Conclusion:The effect of leflunomide in the treatment of rheumatoid arthritis can improve the joint symptoms and reduce the level of CRP and ESR.
作者 王雪娜 Wang Xuena(Department of Rheumatology and Immunology,the Third Hospital of Shandong Province,Shandong Jinna 250031)
出处 《中国社区医师》 2019年第36期23-24,共2页 Chinese Community Doctors
关键词 类风湿关节炎 来氟米特 甲氨蝶呤 Rheumatoid arthritis Leflunomide Methotrexate
  • 相关文献

参考文献6

二级参考文献74

  • 1张强华.类风湿性关节炎的发病机制[J].国外医学(免疫学分册),1994,17(1):40-42. 被引量:12
  • 2包军,徐沪济.小剂量激素在类风湿关节炎治疗中的应用价值[J].国外医学(内科学分册),2006,33(2):78-80. 被引量:3
  • 3冯洪江,许小军,田再泉,邓长泉.来氟米特治疗类风湿性关节炎50例[J].医药导报,2006,25(9):914-916. 被引量:6
  • 4艾脉兴,马丽,赵孟君,王丽英,林冰,王国春,吴东海.依那西普治疗活动性类风湿关节炎的安全性和有效性[J].中国新药杂志,2007,16(15):1208-1211. 被引量:12
  • 5Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis [ J ]. Arthritis Rheum, 1988,31 ( 3 ) : 315-24.
  • 6Strangfeld A, Hierse F, Kekow J, et al. Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide [ J~. Ann Rheum Dis, 2009,68 ( 12 ) : 1856-1862.
  • 7Finckh A, Dehler S, Gabay C. The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis : a population-based study [ J ~. Ann Rheum Dis, 2009,68 ( 1 ) :33-39.
  • 8Curtis JR,Beuke|man T, Onofrei A, et al. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide [ J]. Ann Rheum Dis, 2010,69( 1 ) :43-47.
  • 9Singer O, Gibofsky A. Methotrexate leflunomide in rheumatoid arthritis: what is new in 2011 [J]. Curt Opin Rheumato1,2011,23 ( 3 ) :288-292.
  • 10Leca N. Leflunomide use in renal transplantation [ J]. Curt Opin Organ Transplant,2009,14 (4) :370-374.

共引文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部